VIVO

Hurry! 7 Pitiful Nasdaq Stocks to Sell Before 2022 Ends.

By Omor Ibne Ehsan
As the Fed continues to tighten the market, consider putting these seven on your list of overvalued Nasdaq stocks to sell before 2022 ends.

Meridian Biosciences (VIVO) Stock Trending on $1.5 Billion Buyout Agreement

By David Moadel, InvestorPlace Contributor
VIVO stock is a hot topic on Wall Street today, not just because Meridian Biosciences released a fiscal update, but also due to takeover news.

8 Small-Cap Stocks With Plenty of Cred

By Louis Navellier and the InvestorPlace Research Staff
These eight small-cap stocks are affordable, and they can deliver significant returns, especially during an economic recovery.

7 Overlooked Small-Cap Stocks To Buy For Growth

By Louis Navellier and the InvestorPlace Research Staff
Despite the huge market rally since March, there are still some great value buys among small-cap stocks, if you know where to look.

7 A-Rated Growth Stocks That Are Loaded With Long-Term Potential

By Louis Navellier and the InvestorPlace Research Staff
This selection of growth stocks includes some surprise choices and companies set to benefit from the lasting effects of the pandemic.